Info Sheets , Drug Product , Commercial Manufacturing , Pediatrics , Orphan Rare Diseases

Quotient Sciences' Commercial Manufacturing Capabilities

1 September 2025
Overview

Quotient Sciences offers integrated commercial drug product manufacturing services designed to accelerate time to market and reduce drug product supply chain complexity. 

With capabilities spanning solid oral dosage forms, including high-potency APIs (HPAPIs), we support clients through late-phase trials through to commercial launch and sustained, reliable commercial drug product supply. Operating from FDA- and MHRA-approved facilities, Quotient Sciences provides flexible batch sizes and scalable processes to delivery your drug product supply globally. 

We are equipped to manage complex drug product manufacturing programs across multiple therapeutic areas, offering agile solutions that reduce supply chain risk and accelerate time to market.

Download
Date
1 September 2025
Ask The Experts

Commercial drug product manufacturing questions? Get answers from our team.

Have a question about your commercial drug program? Ask a member of our team about our capabilities for commercial manufacturing from our US-based drug product facilities to keep your product progressing through later development and on-track to reach the market.

Jamie Weishaar

VP, Global Commercial Drug Product

Jamie Weishaar is an experienced business development executive leader specializing in pharmaceutical drug development, including ...

About Jamie
Jeff Folks

Senior Director, Business Development

Jeff Folks is an experienced business development leader specializing in pharmaceutical drug product development. At Quotient Scie...

About Jeff
Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design. Across a broad range of dosage forms and ...

About Robert
Get in touch
Humanity can't afford to wait, so neither can we.